Ireland· IE-PA-EU/1/14/960/001
DUAVIVE 0.45 mg/20 mg modified-release tablets
A other estrogens product containing conjugated estrogens (ce) + bazedoxifene acetate, registered in Ireland by Pfizer Europe MA EEIG.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Conjugated estrogens (ce) + Bazedoxifene acetate
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Ireland (IE)
- ATC code
- G03CX
- ATC class
- Other estrogens
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/14/960/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Conjugated estrogens (ce) + bazedoxifene acetate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDuaveeU.S. Pharmaceuticals
- CzechiaDUAVIVEPfizer Europe MA EEIG, Bruxelles
- SpainDUAVIVE 0,45 MG/20 MG COMPRIMIDOS DE LIBERACION MODIFICADAPfizer Europe Ma Eeig
- FinlandDUAVIVEPfizer Europe MA EEIG
- United KingdomDuavive 0.45mg/20mg modified-release tabletsPfizer Ltd
- CanadaDUAVIVEPFIZER CANADA ULC
- NetherlandsDuavive, 20 mg/ 0.45 mg tablet met gereguleerde afgiftePfizer Europe MA EEIG
- PolandDuavivePfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Duavive
- Liechtenstein · Duavive
- Norway · Duavive
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/09593e7f-9296-4395-9f8d-6820e7469b75 GET /v1/drugs/09593e7f-9296-4395-9f8d-6820e7469b75?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Modified-release tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"G03CX"
],
"strength": null,
"pa_number": "EU/1/14/960/001",
"substances": [
"Conjugated estrogens (ce)",
"Bazedoxifene acetate"
],
"legal_basis": "Fixed combination application (Article 10b of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "16/12/2014",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about conjugated estrogens (ce) + bazedoxifene acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.